475 related articles for article (PubMed ID: 28852878)
1. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.
Rönnberg B; Gustafsson Å; Vapalahti O; Emmerich P; Lundkvist Å; Schmidt-Chanasit J; Blomberg J
Med Microbiol Immunol; 2017 Oct; 206(5):383-401. PubMed ID: 28852878
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
[TBL] [Abstract][Full Text] [Related]
3. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
[TBL] [Abstract][Full Text] [Related]
4. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
[TBL] [Abstract][Full Text] [Related]
5. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections.
Tyson J; Tsai WY; Tsai JJ; Mässgård L; Stramer SL; Lehrer AT; Nerurkar VR; Wang WK
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007649. PubMed ID: 31442225
[TBL] [Abstract][Full Text] [Related]
7. Validation of serological and molecular methods for diagnosis of zika virus infections.
Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
[TBL] [Abstract][Full Text] [Related]
9. Development of Zika Virus Serological Testing Strategies in New York State.
Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
[TBL] [Abstract][Full Text] [Related]
12. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
13. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
14. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
[TBL] [Abstract][Full Text] [Related]
15. Detection of Specific ZIKV IgM in Travelers Using a Multiplexed Flavivirus Microsphere Immunoassay.
Taylor CT; Mackay IM; McMahon JL; Wheatley SL; Moore PR; Finger MJ; Hewitson GR; Moore FA
Viruses; 2018 May; 10(5):. PubMed ID: 29757218
[TBL] [Abstract][Full Text] [Related]
16. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis.
Wong SJ; Furuya A; Zou J; Xie X; Dupuis AP; Kramer LD; Shi PY
EBioMedicine; 2017 Feb; 16():136-140. PubMed ID: 28094237
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new rapid fluorescence immunoassay for the diagnosis of dengue and Zika virus infection.
Zammarchi L; Colao MG; Mantella A; Capobianco T; Mazzarelli G; Ciccone N; Tekle Kiros S; Mantengoli E; Rossolini GM; Bartoloni A
J Clin Virol; 2019 Mar; 112():34-39. PubMed ID: 30738366
[TBL] [Abstract][Full Text] [Related]
19. Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody against Zika Virus Using Monoclonal Antibodies to the Envelope and Non-structural Protein 1 of the Virus.
Kim YH; Lee J; Kim YE; Chong CK; Pinchemel Y; Reisdörfer F; Coelho JB; Dias RF; Bae PK; Gusmão ZPM; Ahn HJ; Nam HW
Korean J Parasitol; 2018 Feb; 56(1):61-70. PubMed ID: 29529852
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
